Total Liabilities for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported total liabilities is $3.36B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$3.36B
YoY change
+12.3%
5Y CAGR
+4.8%
Peak year (2025)
$3.36B
Latest annual
$3.36B
Total Liabilities history chart for Edwards Lifesciences (EW) from 1999 to 2025
Total Liabilities history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $3.36B | +12.3% | ||
| 2024 | $2.99B | +13.2% | ||
| 2023 | $2.64B | +6.4% | ||
| 2022 | $2.49B | -6.8% | ||
| 2021 | $2.67B | +0.1% | ||
| 2020 | $2.66B | +13.8% | ||
| 2019 | $2.34B | +7.2% | ||
| 2018 | $2.18B | -19.2% | ||
| 2017 | $2.70B | +42.9% | ||
| 2016 | $1.89B | +21.5% | ||
| 2015 | $1.56B | +16.8% | ||
| 2014 | $1.33B | +14.4% | ||
| 2013 | $1.17B | +57.0% | ||
| 2012 | $742.20M | +15.5% | ||
| 2011 | $642.60M | +40.0% | ||
| 2010 | $459.00M | +0.3% | ||
| 2009 | $457.60M | -12.2% | ||
| 2008 | $521.40M | +2.2% | ||
| 2007 | $510.10M | +2.6% | ||
| 2006 | $497.40M | -7.7% | ||
| 2005 | $539.10M | +11.2% | ||
| 2004 | $484.60M | +3.9% | ||
| 2003 | $466.30M | -0.5% | ||
| 2002 | $468.80M | -8.8% | ||
| 2001 | $514.00M | -20.7% | ||
| 2000 | $648.00M | +204.2% | ||
| 1999 | $213.00M | — |
Total Liabilities values are taken from Edwards Lifesciences's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Edwards Lifesciences (EW) total liabilities is $3.36B – grew 12.3% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Edwards Lifesciences total liabilities compounded at +4.8% per year, with the latest reading among the more recent periods of the dataset.
2025 marks the peak total liabilities at $3.36B, with the historical low of $213.00M recorded in 1999.
Among 8 Healthcare peers, Edwards Lifesciences (EW) ranks 9th; the peer median for total liabilities is $101.80B.
Edwards Lifesciences Total Liabilities by Year
Edwards Lifesciences Total Liabilities 2025: $3.36B
Edwards Lifesciences total liabilities in 2025 was $3.36B, grew 12.3% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Total Liabilities 2024: $2.99B
Edwards Lifesciences total liabilities in 2024 was $2.99B, grew 13.2% from 2023.
Edwards Lifesciences Total Liabilities 2023: $2.64B
Edwards Lifesciences total liabilities in 2023 was $2.64B, grew 6.4% from 2022.
Edwards Lifesciences Total Liabilities 2022: $2.49B
Edwards Lifesciences total liabilities in 2022 was $2.49B, declined 6.8% below 2021.
Edwards Lifesciences Total Liabilities 2021: $2.67B
Edwards Lifesciences total liabilities in 2021 was $2.67B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Total Liabilities
Companies in the same sector as Edwards Lifesciences, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's total liabilities?
- Latest reported total liabilities for Edwards Lifesciences (EW) is $3.36B (period ending December 31, 2025).
How has Edwards Lifesciences total liabilities changed year-over-year?
- Edwards Lifesciences (EW) total liabilities changed +12.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences total liabilities?
- Edwards Lifesciences (EW) total liabilities compound annual growth rate is +4.8% over the most recent 5 years available.
When did Edwards Lifesciences total liabilities hit its highest annual value?
- Edwards Lifesciences total liabilities reached its highest annual value of $3.36B in 2025.
What was Edwards Lifesciences total liabilities in 2024?
- Edwards Lifesciences (EW) total liabilities in 2024 was $2.99B.
What was Edwards Lifesciences total liabilities in 2025?
- Edwards Lifesciences (EW) total liabilities in 2025 was $3.36B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.